middle.news
PYC Therapeutics Advances RNA Pipeline with $600M Capital and Clinical Milestones
7:11pm on Friday 28th of August, 2026 AEST
•
Biotechnology
Read Story
PYC Therapeutics Advances RNA Pipeline with $600M Capital and Clinical Milestones
7:11pm on Friday 28th of August, 2026 AEST
Key Points
Completed $600 million capital raise extending funding to 2030
Advanced Phase 1b multiple ascending dose trials in PKD and ADOA
PMS program progressing towards first-in-human trials in 2027
Sustained vision improvements reported in RP11 and ADOA patients
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC Therapeutics (ASX:PYC)
OPEN ARTICLE